Geisinger Awarded $2.8M Grant for Familial Hypercholesterolemia Research

Nov 26, 2019

|

NEW YORK — Geisinger said on Tuesday that it has been awarded a four-year grant worth $2.8 million from the National Heart, Lung, and Blood Institute to develop new methods for the identification and cascade testing of familial hypercholesterolemia (FH).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Nobel Representation

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Bill to Address Foreign Influence

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research.

Promising, But More Needed

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

Cell Studies Tackle Tissue Clones, Ocean Microbes, Polygenic Trait Prediction

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.

Featured White Papers

Independent, Third-Party Studies Evaluating the Efficiency of the Twist Human Core Exome Kit for Target Sequencing

The Importance of Coverage Uniformity Over On-Target Rate for Efficient Targeted NGS

KAPA RNA HyperPrep: A Streamlined Library Preparation Workflow that Enables Robust Gene Expression Profiling Using RNA-sequencing

Orthogonal Methods for Validation and Confirmation of Next-Generation Sequencing Results

Dec

17

Featured Webinar

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Dec

19

Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.

Jan

28

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Menu

Geisinger Awarded $2.8M Grant for Familial Hypercholesterolemia Research

To read the full story....

Breaking News

GenMark Diagnostics Downgraded by JP Morgan to Neutral

Twist Bioscience Fiscal Q4 Revenues Increase 87 Percent

Parkinson's Foundation Selects Five Sites for Genetic Testing, Counseling

Oxford BioDynamics Fiscal 2019 Revenues Down 24 Percent

At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

Enzo Biochem Fiscal Q1 Revenues Down 5 Percent

The Scan

Nobel Representation

Bill to Address Foreign Influence

Promising, But More Needed

Cell Studies Tackle Tissue Clones, Ocean Microbes, Polygenic Trait Prediction

Featured White Papers

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

What's Popular?

Parkinson's Foundation Selects Five Sites for Genetic Testing, Counseling

Abu Dhabi Teams Up With BGI, Oxford Nanopore for Population Sequencing Project

At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

Forensic Genomics Firm Verogen Acquires Genealogy Website GEDmatch

Study Shows Feasibility of Circulating Trophoblast-Based Noninvasive Prenatal Testing

Sponsorships